StockNews.com started coverage on shares of DBV Technologies (NASDAQ:DBVT – Free Report) in a report published on Friday. The firm issued a hold rating on the stock.
Separately, JMP Securities restated a “market outperform” rating and issued a $10.00 price target on shares of DBV Technologies in a research note on Friday, January 10th.
View Our Latest Report on DBV Technologies
DBV Technologies Stock Performance
Institutional Investors Weigh In On DBV Technologies
An institutional investor recently bought a new position in DBV Technologies stock. Boxer Capital Management LLC acquired a new position in shares of DBV Technologies S.A. (NASDAQ:DBVT – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 50,000 shares of the company’s stock, valued at approximately $154,000. Boxer Capital Management LLC owned 0.24% of DBV Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 71.74% of the company’s stock.
DBV Technologies Company Profile
DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis.
Further Reading
- Five stocks we like better than DBV Technologies
- How to Most Effectively Use the MarketBeat Earnings Screener
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Using the MarketBeat Dividend Tax Calculator
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for DBV Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV Technologies and related companies with MarketBeat.com's FREE daily email newsletter.